SRD5A2 and emerging therapies in androgen-driven disorders

Nature Reviews Urology · Published 2026-01-07 · DOI 10.1038/s41585-025-01112-9

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1038/s41585-025-01112-9

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Lower androgen sulfate metabolites in women with hypermobile Ehlers-Danlos syndrome may be associated with changed metabolism and disposition · Journal of Steroid Biochemistry and Molecular Biology · 2026 · Cites or is cited by this article
• Urolithiasis in patients with cancer · Nature Reviews Urology · 2026 · Same journal
• Bladder cancer research is blossoming in Birmingham · Nature Reviews Urology · 2026 · Same journal
• Animal models of spinal cord injury in neuro-urological research · Nature Reviews Urology · 2026 · Same journal
• Transitional urology: a comprehensive review of the transitional care process · Nature Reviews Urology · 2026 · Same journal
• Why counting women is not enough: from inclusion to equity in oncology trials · Nature Reviews Urology · 2026 · Same journal
• Polypropylene mesh degradation and systemic disease: biological plausibility is not clinical evidence · Nature Reviews Urology · 2026 · Same journal
• Leveraging generative AI to enhance doctor–patient communication · Nature Reviews Urology · 2026 · Same journal
• Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer · Nature Reviews Urology · 2026 · Same journal
• Implantable pelvic neurostimulators to restore erectile function: from concept to practice · Nature Reviews Urology · 2026 · Same journal